Tue. 12 Mar 2024, 8:06am ET
Benzinga
Earnings, News
Ikena Oncology (NASDAQ:IKNA) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.43) by 4.65 percent. This is a 5.13 percent decrease over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $658.00 thousand which missed the analyst consensus estimate of $3.14 million by 79.04 percent. This is a 87.93 percent decrease over sales of $5.45 million the same period last year.